The executive team at Synthetic Genomics has a history of working in various finance-related positions at different companies. These include Halozyme Therapeutics, Inc., CareFusion, and PricewaterhouseCoopers. They also have experience in M&A, integration, and separation consulting. Their educational backgrounds are in business and government from Questrom School of Business, Boston University, and Wesleyan University, respectively.
View all